These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35149583)

  • 21. Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.
    Knarborg M; Løkke A; Hilberg O; Ibsen R; Sikjaer MG
    Respirology; 2022 May; 27(5):341-349. PubMed ID: 35224821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.
    Papanicolaou S; Pons ME; Hampel C; Monz B; Quail D; Schulenburg MG; Wagg A; Sykes D
    Maturitas; 2005 Nov; 52 Suppl 2():S35-47. PubMed ID: 16297577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paediatric emergency department utilisation rates and maternal migration status in the Born in Bradford cohort: A cross-sectional study.
    Credé SH; Mason S; Such E; Jacques RM
    PLoS Med; 2020 Mar; 17(3):e1003043. PubMed ID: 32126079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study.
    Hong J; Reed C; Novick D; Haro JM; Windmeijer F; Knapp M
    Pharmacoeconomics; 2010; 28(7):555-66. PubMed ID: 20405969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
    Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
    BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study.
    Liebl A; Breitscheidel L; Nicolay C; Happich M
    Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
    Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
    BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The direct and indirect costs of Dravet Syndrome.
    Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
    Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.
    Jackson AD; Jackson AL; Fletcher G; Doyle G; Harrington M; Zhou S; Cullinane F; Gallagher C; McKone E
    Pharmacoeconomics; 2017 Oct; 35(10):1087-1101. PubMed ID: 28699086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey.
    Morris S; Vallortigara J; Greenfield J; Hunt B; Hoffman D; Reinhard C; Graessner H; Federico A; Quoidbach V; Giunti P
    Orphanet J Rare Dis; 2023 Dec; 18(1):382. PubMed ID: 38062507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care utilisation and costs in the general population in Germany.
    Grupp H; König HH; Konnopka A
    Health Policy; 2016 Feb; 120(2):159-69. PubMed ID: 26797256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs.
    Kamps AW; Roorda RJ; Kimpen JL; Overgoor-van de Groes AW; van Helsdingen-Peek LC; Brand PL
    Eur Respir J; 2004 Feb; 23(2):304-9. PubMed ID: 14979508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of work injuries and diseases: a framework and application in five European Union countries.
    Tompa E; Mofidi A; van den Heuvel S; van Bree T; Michaelsen F; Jung Y; Porsch L; van Emmerik M
    BMC Public Health; 2021 Jan; 21(1):49. PubMed ID: 33407315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
    Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
    Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
    Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D
    Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.